<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(16)</volume><submitter>Borges VFA</submitter><pubmed_abstract>Cholangiopathy has been described in survivors of severe COVID-19, presenting significant clinical parallels to the pre-pandemic condition of secondary sclerosing cholangitis in critically ill patients (SSC-CIP). We aimed to examine the liver histopathology of individuals with persistent cholestasis after severe COVID-19.&lt;h4>Methods&lt;/h4>We subjected post-COVID-19 cholestasis liver samples to routine staining techniques and cytokeratin 7 immunostaining and semi-quantitatively analyzed the portal and parenchymal changes.&lt;h4>Results&lt;/h4>All ten patients, five men, had a median age of 56, an interquartile range (IQR) of 51-60, and required intensive care unit and mechanical ventilation. The median and IQR liver enzyme concentrations proximal to biopsy were in IU/L: ALP 645 (390-1256); GGT 925 </pubmed_abstract><journal>Diagnostics (Basel, Switzerland)</journal><pagination>1804</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11354040</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>COVID-19-Related Cholangiopathy: Histological Findings.</pubmed_title><pmcid>PMC11354040</pmcid><pubmed_authors>Borges VFA</pubmed_authors><pubmed_authors>Silva MC</pubmed_authors><pubmed_authors>Freitas LAR</pubmed_authors><pubmed_authors>Andrade ARCF</pubmed_authors><pubmed_authors>Salomao FC</pubmed_authors><pubmed_authors>Cotrim HP</pubmed_authors><pubmed_authors>Mendes LSC</pubmed_authors><pubmed_authors>Penna FGC</pubmed_authors></additional><is_claimable>false</is_claimable><name>COVID-19-Related Cholangiopathy: Histological Findings.</name><description>Cholangiopathy has been described in survivors of severe COVID-19, presenting significant clinical parallels to the pre-pandemic condition of secondary sclerosing cholangitis in critically ill patients (SSC-CIP). We aimed to examine the liver histopathology of individuals with persistent cholestasis after severe COVID-19.&lt;h4>Methods&lt;/h4>We subjected post-COVID-19 cholestasis liver samples to routine staining techniques and cytokeratin 7 immunostaining and semi-quantitatively analyzed the portal and parenchymal changes.&lt;h4>Results&lt;/h4>All ten patients, five men, had a median age of 56, an interquartile range (IQR) of 51-60, and required intensive care unit and mechanical ventilation. The median and IQR liver enzyme concentrations proximal to biopsy were in IU/L: ALP 645 (390-1256); GGT 925 </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2025-04-04T10:38:18.775Z</modification><creation>2024-10-16T14:22:11.314Z</creation></dates><accession>S-EPMC11354040</accession><cross_references><pubmed>39202292</pubmed><doi>10.3390/diagnostics14161804</doi></cross_references></HashMap>